{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:08:45Z","timestamp":1787425725989,"version":"build-2736575974"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Pulmonary function tests (PFTs) are essential for predicting outcomes in interstitial lung disease (ILD). In 2022, an expert panel recommended using <jats:italic>z<\/jats:italic>-scores instead of the traditional % predicted cut-off values to interpret the severity of PFT abnormalities which may lead to discordant classifications in some patients. To assess the magnitude and prognostic impact of this phenomenon we compared these two approaches in predicting all-cause mortality in a large cohort of patients with ILDs.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and findings<\/jats:title>\n<jats:p>We retrospectively analyzed data from a tertiary referral center for patients with ILDs. Absolute FEV<jats:sub>1<\/jats:sub>, FVC, TLC, and TLCO values from patients\u2019 first presentations were transformed and presented as % predicted and <jats:italic>z<\/jats:italic>-scores using the most recent global lung initiative (GLI) reference values. Results were categorized for severity according to % predicted and <jats:italic>z<\/jats:italic>-score levels. Predictors of all-cause mortality over a 14-year follow-up were determined using Kaplan\u2013Meier survival analysis and Cox proportional hazards regression. Between January 2009 and March 2023, 6,808 patients with ILDs were evaluated at the National TB and Lung Diseases Research Institute in Warsaw, Poland. Most were diagnosed with sarcoidosis, fibrotic ILD, or non-fibrotic ILD. At their first presentation, 13.2% had airway obstruction, 23.1% had low FVC (indicative of restriction by spirometry), and 45.6% had a reduced lung transfer factor (TLCO). Reclassification of spirometric indices occurred in 26.8% of patients for FEV<jats:sub>1<\/jats:sub> and 24.6% for FVC among those with abnormal results, with most being reassigned to a less severe categories. For TLCO, 28.1% of patients with reduced values were reclassified, with most shifting to more severe categories. During the follow-up, 1,525 (22.4%) of patients died. Both low FVC and low TLCO predicted all-cause mortality, with <jats:italic>z<\/jats:italic>-score thresholds showing stronger associations with mortality. A one-unit decrease in the FVC <jats:italic>z<\/jats:italic>-score was associated with a 10.3% increase in the risk of death, while a one-unit decrease in TLCO <jats:italic>z<\/jats:italic>-score was linked to an over 30% increase in mortality risk. Limitations of this retrospective single-center study include lack of data on cause-specific mortality, potential residual confounding, and limited generalizability to non-Caucasian or younger populations.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The recently recommended use of <jats:italic>z<\/jats:italic>-scores leads to significant reclassification of lung function results in patients with ILDs, largely driven by age. This approach is justified by its stronger prognostic associations. Severe TLCO impairment remains a robust predictor of mortality in ILDs.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pmed.1004619","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T17:58:47Z","timestamp":1748541527000},"page":"e1004619","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Assessment of lung function and severity grading in interstitial lung diseases (% predicted versus z-scores) and association with survival: A retrospective cohort study of 6,808 patients"],"prefix":"10.1371","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9153-8919","authenticated-orcid":true,"given":"Piotr W.","family":"Boros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7027-757X","authenticated-orcid":true,"given":"Magdalena M.","family":"Martusewicz-Boros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4648-2864","authenticated-orcid":true,"given":"Katarzyna B.","family":"Lewandowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"issue":"10","key":"pmed.1004619.ref001","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"B Ley","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"pmed.1004619.ref002","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1164\/rccm.201011-1790OC","article-title":"Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis","volume":"184","author":"RM du Bois","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"pmed.1004619.ref003","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"R Pellegrino","year":"2005","journal-title":"Eur Respir J"},{"issue":"1","key":"pmed.1004619.ref004","doi-asserted-by":"crossref","first-page":"2101499","DOI":"10.1183\/13993003.01499-2021","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"S Stanojevic","year":"2021","journal-title":"Eur Respir J"},{"issue":"4","key":"pmed.1004619.ref005","first-page":"657","article-title":"A new staging strategy for chronic obstructive pulmonary disease","volume":"2","author":"MR Miller","year":"2007","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"pmed.1004619.ref006","doi-asserted-by":"crossref","first-page":"2002046","DOI":"10.1183\/13993003.02046-2020","article-title":"Reduction in TLCO and survival in a clinical population","volume":"58","author":"MR Miller","year":"2021","journal-title":"Eur Respir J"},{"issue":"2","key":"pmed.1004619.ref007","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1183\/09031936.00086313","article-title":"Grading the severity of airways obstruction: new wine in new bottles","volume":"43","author":"PH Quanjer","year":"2014","journal-title":"Eur Respir J"},{"issue":"8","key":"pmed.1004619.ref008","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society Technical Statement","volume":"200","author":"BL Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pmed.1004619.ref009","doi-asserted-by":"crossref","first-page":"1600016","DOI":"10.1183\/13993003.00016-2016","article-title":"2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung","volume":"49","author":"BL Graham","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"pmed.1004619.ref010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1183\/09031936.05.00035005","article-title":"Standardisation of the measurement of lung volumes","volume":"26","author":"J Wanger","year":"2005","journal-title":"Eur Respir J"},{"issue":"2","key":"pmed.1004619.ref011","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"MR Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"4","key":"pmed.1004619.ref012","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1183\/09031936.05.00034905","article-title":"Standardisation of the single-breath determination of carbon monoxide uptake in the lung","volume":"26","author":"N MacIntyre","year":"2005","journal-title":"Eur Respir J"},{"issue":"3","key":"pmed.1004619.ref013","doi-asserted-by":"crossref","first-page":"2000289","DOI":"10.1183\/13993003.00289-2020","article-title":"Official ERS technical standard: global lung function initiative reference values for static lung volumes in individuals of European ancestry","volume":"57","author":"GL Hall","year":"2021","journal-title":"Eur Respir J"},{"issue":"3","key":"pmed.1004619.ref014","doi-asserted-by":"crossref","first-page":"1700010","DOI":"10.1183\/13993003.00010-2017","article-title":"Official ERS technical standards: global lung function initiative reference values for the carbon monoxide transfer factor for Caucasians","volume":"50","author":"S Stanojevic","year":"2017","journal-title":"Eur Respir J"},{"issue":"6","key":"pmed.1004619.ref015","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations","volume":"40","author":"PH Quanjer","year":"2012","journal-title":"Eur Respir J"},{"issue":"4","key":"pmed.1004619.ref016","doi-asserted-by":"crossref","first-page":"1750010","DOI":"10.1183\/13993003.50010-2017","article-title":"\u201cOfficial ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians.\u201d Sanja Stanojevic, Brian L. Graham, Brendan G. Cooper, Bruce R. Thompson, Kim W. Carter, Richard W. Francis and Graham L. Hall on behalf of the Global Lung Function Initiative TLCO working group. Eur Respir J 2017; 50: 1700010.","volume":"56","author":"Society ER","year":"2020","journal-title":"Eur Respir J"},{"issue":"5","key":"pmed.1004619.ref017","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1164\/ajrccm\/144.5.1202","article-title":"Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.","volume":"144","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"9","key":"pmed.1004619.ref018","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"205","author":"G Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"pmed.1004619.ref019","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1183\/09031936.00166809","article-title":"Impaired lung compliance and DL,CO but no restrictive ventilatory defect in sarcoidosis","volume":"36","author":"PW Boros","year":"2010","journal-title":"Eur Respir J"},{"issue":"1","key":"pmed.1004619.ref020","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-022-02006-9","article-title":"Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype?","volume":"23","author":"J Guiot","year":"2022","journal-title":"Respir Res"},{"issue":"4","key":"pmed.1004619.ref021","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202206-1041ST","article-title":"Syndrome of combined pulmonary fibrosis and emphysema: an official ATS\/ERS\/JRS\/ALAT research statement","volume":"206","author":"V Cottin","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"pmed.1004619.ref022","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults: an official ATS\/JRS\/ALAT clinical practice guideline","volume":"202","author":"G Raghu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"pmed.1004619.ref023","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"G Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"pmed.1004619.ref024","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline","volume":"201","author":"ED Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"pmed.1004619.ref025","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/thoraxjnl-2021-218440","article-title":"Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis","volume":"78","author":"A Chandel","year":"2023","journal-title":"Thorax"},{"issue":"12","key":"pmed.1004619.ref026","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1164\/rccm.201105-0840OC","article-title":"Forced vital capacity in patients with idiopathic pulmonary fibrosis","volume":"184","author":"RM du Bois","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"pmed.1004619.ref027","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.200302-219OC","article-title":"Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia","volume":"168","author":"VN Lama","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"pmed.1004619.ref028","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1164\/rccm.200210-1245OC","article-title":"Fibrotic idiopathic interstitial pneumonia","volume":"168","author":"PI Latsi","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"pmed.1004619.ref029","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1164\/rccm.200209-1112OC","article-title":"Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia","volume":"168","author":"KR Flaherty","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"pmed.1004619.ref030","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1164\/rccm.200211-1311OC","article-title":"Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis","volume":"168","author":"HR Collard","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"pmed.1004619.ref031","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1164\/rccm.200604-488OC","article-title":"Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test","volume":"174","author":"KR Flaherty","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"pmed.1004619.ref032","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/resp.14204","article-title":"Short-term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis","volume":"27","author":"C Macaluso","year":"2022","journal-title":"Respirology"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T17:58:56Z","timestamp":1748541536000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004619"}},"subtitle":[],"editor":[{"given":"Megan B.","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004619","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]}}}